Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

DY131 activates USP17L2. 2 / 2

| 2

➶

reach

"Inversely, Esrrb knockdown resulted in a 40% decrease of DY131 mediated Dub3 transcription, while Sox2 knockdown using a previously published RNAi sequence (Walker et al., 2007) did not strongly affec[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

24207026

➶

reach

"ERRbeta knockdown in and DY131 stimulation of mouse ESCs reduces or enhances Dub3 and Cdc25A, respectively, and RNAi mediated inhibition of Dub3 or Cdc25A led these cells to differentiate."

27507929

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...